4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-26-000006
CEO and CFO bought 2,900 shares at $21.73 ($63,017)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2025-12-30 | Purchase | +2,900 | $21.73 | $63,017 | 5,595,102 | D: show line 1 in the form |
| Open-market purchases · 2,900 sh · avg $21.73 · $63,017 | |||||||
Loading xslF345X05/ownership.xml…